VIV:NYSETelefonica Brasil S.A. Analysis
Data as of 2026-08-28 - not real-time
$11.26
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At $11.26, Telefônica Brasil S.A. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 19.3% over the past 30 days. RSI sits at 32.7, which reads as approaching oversold, and MACD momentum is bullish. Watch $11.18 as support and $12.95 as the nearer resistance level.
Multiples put this in undervalued territory: 14.1 times earnings against the sector's 16.3. Consensus targets land 32.2% above where the shares trade now. Revenue is growing at 7.6% on a 10.7% profit margin. The 8.77% dividend yield looks stretched against payout coverage.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 30.4%, a beta of 0.60 and a maximum drawdown of 34.5%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.
Multiples put this in undervalued territory: 14.1 times earnings against the sector's 16.3. Consensus targets land 32.2% above where the shares trade now. Revenue is growing at 7.6% on a 10.7% profit margin. The 8.77% dividend yield looks stretched against payout coverage.
The composite risk read is 6/10, putting it in elevated territory. With 30-day volatility of 30.4%, a beta of 0.60 and a maximum drawdown of 34.5%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.
Top Market Events
Seeking Alpha1monTelefônica Brasil S.A. VIV Q2 2026 Earnings Call TranscriptGood morning, ladies and gentlemen....Detailed price information for Telecomunicacoes DE Sao Paulo ADR VIV-N from The Globe and Mail including charting and...Detailed price information for Telecomunicacoes DE Sao Paulo ADR VIV-N from The Globe and Mail including charting and...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 13.88
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 14.1 versus sector average of 16.3
- Dividend yield of 8.77% looks stretched against payout coverage
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 14.1 versus sector average of 16.3
- Dividend yield of 8.77% looks stretched against payout coverage
- Analyst targets imply +32.2% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth7.60%
Profit Margin10.68%
P/E Ratio14.1
ROE9.87%
ROA5.51%
Debt/Equity30.21
P/B Ratio2.7
Op. Cash Flow$20.2B
Free Cash Flow$12.6B
Industry P/E16.3
Technical Analysis
TrendBearish
RSI32.7
Support$11.18
Resistance$12.95
MA 20$11.67
MA 50$12.75
MA 200$13.88
MACDBullish
VolumeDecreasing
Fear & Greed Index95.3
Valuation
Fair Value$132.72
Target Price$14.87
Upside/Downside32.15%
GradeUndervalued
TypeValue
Dividend Yield8.77%
Risk Assessment
Beta0.60
Volatility30.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.